v3.4.0.3
STOCKHOLDERS' EQUITY: (Tables)
|
12 Months Ended |
|
|---|
| STOCKHOLDERS' EQUITY: |
|
| Schedule of option activity |
|
|
|
Number
of shares
|
|
Weighted-
average exercise
price
per share
|
|
Weighted-
average
remaining
contractual
term (in
years)
|
|
Aggregate
intrinsic value
(in thousands)
|
|
|
Outstanding at March 31, 2015
|
|
4,870,219
|
|
$
|
15.10
|
|
|
|
|
|
|
Granted
|
|
445,785
|
|
$
|
17.84
|
|
|
|
|
|
|
Exercised
|
|
(923,958
|
)
|
$
|
8.51
|
|
|
|
$
|
10,746
|
|
|
Forfeited or cancelled
|
|
(787,944
|
)
|
$
|
27.05
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Outstanding at March 31, 2016
|
|
3,604,102
|
|
$
|
14.52
|
|
5.20
|
|
$
|
25,883
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Exercisable at March 31, 2016
|
|
2,486,647
|
|
$
|
14.62
|
|
3.90
|
|
$
|
17,777
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Summary of stock options outstanding and exercisable |
|
|
|
Options outstanding
|
|
Options exercisable
|
|
|
Range of
exercise price
per share
|
|
Options
outstanding
|
|
Weighted- average
remaining
contractual life
|
|
Weighted-average
exercise price
per share
|
|
Options
exercisable
|
|
Weighted-average
exercise price
per share
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$ 0.63 - $ 8.90
|
|
690,255
|
|
6.83 years
|
|
$
|
1.80
|
|
387,703
|
|
$
|
1.82
|
|
|
$ 11.08 - $ 14.21
|
|
1,052,358
|
|
4.66 years
|
|
$
|
13.32
|
|
985,021
|
|
$
|
13.32
|
|
|
$ 15.31 - $ 19.76
|
|
819,902
|
|
5.54 years
|
|
$
|
17.16
|
|
404,855
|
|
$
|
16.54
|
|
|
$ 20.27 - $ 24.53
|
|
1,021,945
|
|
4.35 years
|
|
$
|
21.87
|
|
699,204
|
|
$
|
22.18
|
|
|
$ 27.77 - $ 32.85
|
|
19,642
|
|
7.58 years
|
|
$
|
32.83
|
|
9,864
|
|
$
|
32.80
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
3,604,102
|
|
5.20 years
|
|
$
|
14.52
|
|
2,486,647
|
|
$
|
14.62
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Schedule of stock appreciation right (SAR) activity |
|
|
|
Number
of shares
|
|
Weighted-
average exercise
price
per share
|
|
Weighted-
average
remaining
contractual
term (in
years)
|
|
Aggregate
intrinsic value
(in thousands)
|
|
|
Outstanding at March 31, 2015
|
|
245,404
|
|
$
|
40.00
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Outstanding at March 31, 2016
|
|
245,404
|
|
$
|
40.00
|
|
1.00
|
|
$
|
—
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Exercisable at March 31, 2016
|
|
—
|
|
$
|
—
|
|
—
|
|
$
|
—
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Schedule of non-vested time-vesting restricted stock units activity |
|
|
|
Number
of shares
|
|
Weighted
average fair
value per
share at grant
date
|
|
Weighted-
average
remaining
contractual
term (in years)
|
|
|
Outstanding at March 31, 2015
|
|
2,053,179
|
|
$
|
20.44
|
|
1.95
|
|
|
Granted
|
|
1,427,561
|
|
$
|
18.89
|
|
|
|
|
Vested
|
|
(975,744
|
)
|
$
|
20.16
|
|
|
|
|
Forfeited or cancelled
|
|
(225,101
|
)
|
$
|
19.41
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Outstanding at March 31, 2016
|
|
2,279,895
|
|
$
|
19.69
|
|
2.12
|
|
|
|
|
|
|
|
|
|
|
|
|
| Schedule of non-vested performance-based restricted stock units activity |
|
|
|
Number
of shares
|
|
Weighted
average fair
value per
share at grant
date
|
|
Weighted-
average
remaining
contractual
term (in years)
|
|
|
Outstanding at March 31, 2015
|
|
389,310
|
|
$
|
21.12
|
|
1.57
|
|
|
Granted
|
|
367,807
|
|
$
|
18.42
|
|
|
|
|
Forfeited or cancelled
|
|
(240,299
|
)
|
$
|
22.35
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Outstanding at March 31, 2016
|
|
516,818
|
|
$
|
18.62
|
|
1.67
|
|
|
|
|
|
|
|
|
|
|
|
|
| Schedule of other performance unit activity |
|
|
|
Number
of shares
|
|
Weighted
average fair
value per
share at grant
date
|
|
Weighted-
average
remaining
contractual
term (in years)
|
|
|
Outstanding at March 31, 2015
|
|
312,575
|
|
$
|
5.23
|
|
|
|
|
Granted
|
|
323,080
|
|
$
|
2.94
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Outstanding at March 31, 2016
|
|
635,655
|
|
$
|
4.07
|
|
1.30
|
|
|
|
|
|
|
|
|
|
|
|
|
| Schedule of accumulated balances for each component of other comprehensive income |
The accumulated balances for each component of other comprehensive income was (dollars in thousands):
|
|
|
March 31,
2016
|
|
March 31,
2015
|
|
|
Foreign currency translation
|
|
$
|
8,705
|
|
$
|
9,612
|
|
|
Unrealized loss on interest rate swap
|
|
(115
|
)
|
(199
|
)
|
|
|
|
|
|
|
|
|
|
|
$
|
8,590
|
|
$
|
9,413
|
|
|
|
|
|
|
|
|
|
|
|
| X |
- References
+ Details
| Name: |
us-gaap_EquityAbstract |
| Namespace Prefix: |
us-gaap_ |
| Data Type: |
xbrli:stringItemType |
| Balance Type: |
na |
| Period Type: |
duration |
|
| X |
- DefinitionTabular disclosure of the components of accumulated other comprehensive income (loss).
| Name: |
us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock |
| Namespace Prefix: |
us-gaap_ |
| Data Type: |
nonnum:textBlockItemType |
| Balance Type: |
na |
| Period Type: |
duration |
|
| X |
- DefinitionTabular disclosure of the changes in outstanding nonvested performance-based units.
| Name: |
us-gaap_ScheduleOfNonvestedPerformanceBasedUnitsActivityTableTextBlock |
| Namespace Prefix: |
us-gaap_ |
| Data Type: |
nonnum:textBlockItemType |
| Balance Type: |
na |
| Period Type: |
duration |
|
| X |
- DefinitionTabular disclosure of the number and weighted-average grant date fair value for restricted stock units that were outstanding at the beginning and end of the year, and the number of restricted stock units that were granted, vested, or forfeited during the year.
| Name: |
us-gaap_ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock |
| Namespace Prefix: |
us-gaap_ |
| Data Type: |
nonnum:textBlockItemType |
| Balance Type: |
na |
| Period Type: |
duration |
|
| X |
- DefinitionTabular disclosure of option exercise prices, by grouped ranges, including the upper and lower limits of the price range, the number of shares under option, weighted average exercise price and remaining contractual option terms.
| Name: |
us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTextBlock |
| Namespace Prefix: |
us-gaap_ |
| Data Type: |
nonnum:textBlockItemType |
| Balance Type: |
na |
| Period Type: |
duration |
|
| X |
- DefinitionTabular disclosure of the number and weighted-average exercise prices (or conversion ratios) for stock appreciation rights awards that were outstanding at the beginning and end of the year, and the number of stock appreciation rights awards that were granted, exercised or converted, forfeited, and expired during the year.
| Name: |
us-gaap_ScheduleOfShareBasedCompensationStockAppreciationRightsAwardActivityTableTextBlock |
| Namespace Prefix: |
us-gaap_ |
| Data Type: |
nonnum:textBlockItemType |
| Balance Type: |
na |
| Period Type: |
duration |
|
| X |
- DefinitionTabular disclosure of the number and weighted-average exercise prices (or conversion ratios) for share options (or share units) that were outstanding at the beginning and end of the year, vested and expected to vest, exercisable or convertible at the end of the year, and the number of share options or share units that were granted, exercised or converted, forfeited, and expired during the year.
| Name: |
us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock |
| Namespace Prefix: |
us-gaap_ |
| Data Type: |
nonnum:textBlockItemType |
| Balance Type: |
na |
| Period Type: |
duration |
|
| X |
- DefinitionTabular disclosure of the number and weighted-average grant date fair value for unvested performance shares.
| Name: |
us-gaap_ShareBasedCompensationPerformanceSharesAwardUnvestedActivityTableTextBlock |
| Namespace Prefix: |
us-gaap_ |
| Data Type: |
nonnum:textBlockItemType |
| Balance Type: |
na |
| Period Type: |
duration |
|
|
